Petta S - Search Results

1

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.

Donati B, Pietrelli A, Pingitore P, Dongiovanni P, Caddeo A, Walker L, Baselli G, Pelusi S, Rosso C, Vanni E, Daly A, Mancina RM, Grieco A, Miele L, Grimaudo S, Craxi A, Petta S, De Luca L, Maier S, Soardo G, Bugianesi E, Colli F, Romagnoli R, Anstee QM, Reeves HL, Fracanzani AL, Fargion S, Romeo S, Valenti L. Donati B, et al. Among authors: petta s. Cancer Med. 2017 Aug;6(8):1930-1940. doi: 10.1002/cam4.1078. Epub 2017 Jul 4. Cancer Med. 2017. PMID: 28677271 Free PMC article.

2

Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?

Lo Iacono O, Petta S, Venezia G, Di Marco V, Tarantino G, Barbaria F, Mineo C, De Lisi S, Almasio PL, Craxì A. Lo Iacono O, et al. Among authors: petta s. Am J Gastroenterol. 2005 Nov;100(11):2472-7. doi: 10.1111/j.1572-0241.2005.00244.x. Am J Gastroenterol. 2005. PMID: 16279902

3

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.

Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A. Petta S, et al. Am J Gastroenterol. 2008 May;103(5):1136-44. doi: 10.1111/j.1572-0241.2008.01813.x. Am J Gastroenterol. 2008. PMID: 18477344

4

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.

Petta S, Cammà C, Di Marco V, Alessi N, Barbaria F, Cabibi D, Caldarella R, Ciminnisi S, Licata A, Massenti MF, Mazzola A, Tarantino G, Marchesini G, Craxì A. Petta S, et al. Hepatology. 2008 Jul;48(1):28-37. doi: 10.1002/hep.22316. Hepatology. 2008. PMID: 18506842

5

Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.

Cammà C, Petta S, Di Marco V, Bronte F, Ciminnisi S, Licata G, Peralta S, Simone F, Marchesini G, Craxì A. Cammà C, et al. Among authors: petta s. Hepatology. 2009 Jan;49(1):195-203. doi: 10.1002/hep.22655. Hepatology. 2009. PMID: 19065558

6

Non-alcoholic fatty liver disease pathogenesis: the present and the future.

Petta S, Muratore C, Craxì A. Petta S, et al. Dig Liver Dis. 2009 Sep;41(9):615-25. doi: 10.1016/j.dld.2009.01.004. Epub 2009 Feb 14. Dig Liver Dis. 2009. PMID: 19223251 Review.

7

Hepatitis C and diabetes: the inevitable coincidence?

Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P. Lonardo A, et al. Among authors: petta s. Expert Rev Anti Infect Ther. 2009 Apr;7(3):293-308. doi: 10.1586/eri.09.3. Expert Rev Anti Infect Ther. 2009. PMID: 19344243 Review.

8

Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.

Petta S, Cammà C, Di Marco V, Cabibi D, Ciminnisi S, Caldarella R, Licata A, Massenti MF, Marchesini G, Craxì A. Petta S, et al. Antivir Ther. 2009;14(5):631-9. Antivir Ther. 2009. PMID: 19704165

9

Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association.

Petta S, Craxì A. Petta S, et al. Curr Pharm Des. 2010;16(6):741-52. doi: 10.2174/138161210790883787. Curr Pharm Des. 2010. PMID: 20388084 Review.

10

Optimal therapy in hepatitis C virus genotypes 2 and 3 patients.

Petta S, Craxì A. Petta S, et al. Liver Int. 2011 Jan;31 Suppl 1:36-44. doi: 10.1111/j.1478-3231.2010.02382.x. Liver Int. 2011. PMID: 21205136 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters